Latest News about BGNE

Recent news which mentions BGNE

< Previous 1 2 3 4 5 6 7 Next >

Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors

December 27, 2022

Zymeworks Cancer Candidate Shows Objective Response Of 41% In Bile Duct Cancer

December 19, 2022

BeiGene Earnings Perspective: Return On Capital Employed

December 12, 2022

PayPal To Rally Around 47%? Here Are 10 Other Price Target Changes For Monday

December 12, 2022

What 5 Analyst Ratings Have To Say About BeiGene

December 12, 2022

Will Investors Notice Exciting Sign On BeiGene's Chart?

December 06, 2022

Why Shares of BeiGene Were Up Wednesday

December 01, 2022

Why Leslie's Shares Are Trading Lower By Over 9%? Here Are 60 Stocks Moving In Wednesday's Mid-Day Session

November 30, 2022

Workday, XPeng, Titan Machinery And Some Other Big Stocks Moving Higher On Wednesday

November 30, 2022

Why Horizon Therapeutics Shares Are Trading Higher By Over 30%; Here Are 32 Stocks Moving Premarket

November 30, 2022

Quant Ratings Updated on 59 Stocks

November 29, 2022

Dollar Tree, Dycom Industries, Chico's FAS And Other Big Losers From Tuesday

November 23, 2022

What 4 Analyst Ratings Have To Say About BeiGene

November 10, 2022

Tesla, Amazon, Coupang, Rivian, Beigene: Musk's Share Sale, Antitrust Lawsuit, Earnings Grab Retail Investors' Eyeballs

November 09, 2022

Is This Chinese Pharmaceutical Stock Worth the Risk?

November 03, 2022

Jazz Obtains Exclusive Rights To Zymeworks' Cancer Candidate In Almost $2B Biobuck Deal

October 19, 2022

New Drugs Approvals Bring No Relief for Ailing Innovent Bio

October 18, 2022

European Heath Agency's Committee Backs Approving BeiGene's Brukinsa In Leukemia Setting

October 14, 2022

Analyst Ratings for BeiGene

October 13, 2022

Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022

October 13, 2022

BeiGene's Brukinsa Shows Superior Progression-Free Survival Versus JNJ's Treatment

October 12, 2022

UK's NICE Recommends BeiGene's Cancer Drug For Rare Form Of Blood Cancer

September 20, 2022

BeiGene's Tislelizumab Shows Non-Inferiority In Overall Survival, Safety Vs Standard Treatment In Solid Tumors

September 12, 2022

Junshi Biosciences Hits Revenue Roadblock Amid Covid Drug Delay

September 09, 2022

U.S.-China Audit Deal Won't Slow Hong Kong Dual Listing Train, Analysts Say

September 02, 2022

7 Chinese Stocks to Sell While You Still Can

September 02, 2022

Why Bed Bath & Beyond Jumped Around 25%; Here Are 68 Biggest Movers From Yesterday

August 30, 2022

Catalent, Tellurian And Other Big Losers From Monday

August 30, 2022

U.S.-China relations just got a whole lot better, boosting the prospects of these three stocks

August 28, 2022

Why Splunk Is Trading Lower By Around 10%; Here Are 28 Stocks Moving Premarket

August 25, 2022

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.